COMMUNIQUÉS West-GlobeNewswire

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
14/07/2025
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase SCOTTSDALE, Ariz., July [...]
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
14/07/2025
Borvo Medical to showcase innovative EVAC™ system at Society of Neurointerventional Surgery Annual Meeting MOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Borvo Medical , a neurosurgical medtech startup and a [...]
NEXGEL and STADA AG Announce Expansion of Partnership for North America
14/07/2025
LANGHORNE, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer [...]
Pineapple, Inc. to Launch Real-World Asset Token Designed to Monetize Intellectual Property
14/07/2025
Tokenized IP platform built to enable access, utility, and engagement with Pineapple branded proprietary assets LOS ANGELES, CA, July 14, 2025 (GLOBE NEWSWIRE) -- Pineapple, Inc. (OTC: PNPL) (“Pineapple” or the “Company [...]
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
14/07/2025
First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting antibiotic-resistant lung infections in Cystic Fibrosis patients; topline results are expected in [...]
Dr. Anosh Ahmed Foundation Launches Chicago-Based Initiative to Support Families of Fallen FBI Agents and Law Enforcement Officers
14/07/2025
In response to public support and growing community need, the foundation announces a new phase of local engagement and charitable efforts CHICAGO, July 14, 2025 (GLOBE NEWSWIRE) -- The Dr. Anosh Ahmed Foundation has [...]
Positive Response Fuels New Efforts by Dr. Anosh Ahmed and the Anosh Inc. Foundation to Support Families of Fallen Officers and FBI Agents
14/07/2025
Driven by public support and community need, the Anosh Inc. Foundation prepares new initiatives to deliver lasting impact CHICAGO, July 14, 2025 (GLOBE NEWSWIRE) -- A growing wave of public support continues to surround [...]
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery
14/07/2025
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]
Ascentage Pharma Announces Proposed Top-Up Placement
14/07/2025
ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage ” or the “ Company ”), a global biopharmaceutical company dedicated [...]
Anavar for Women: Exploring the Rise of Anvarol Performance Supplement Among Female Bodybuilders and Athletes From CrazyBulk
14/07/2025
Anavar for Women is trending in 2025 as fitness-focused women seek safer, effective cutting support. Discover how Anvarol is emerging as a leading legal alternative tailored for lean muscle tone, stamina, and strength— [...]
NTG Nordic Transport Group A/S - H1 2025 Conference Call
14/07/2025
NTG Nordic Transport Group A/S – H1 2025 Conference Call We expect to release the H1 2025 interim results of NTG Nordic Transport Group on the evening of August 11, 2025. A webcast and conference call will be held in [...]
OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025
14/07/2025
PRESS RELEASE OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025 OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including [...]
Menerals Launches in San Diego with Bold Mission to Restore Strength and Masculinity Through Real Nutrition
13/07/2025
New men’s health supplement brand introduces 100+ trace minerals to combat nutrient deficiency, testosterone decline, and performance burnout San Diego, CA, July 13, 2025 (GLOBE NEWSWIRE) -- Menerals, a new men’s health [...]
Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025
13/07/2025
Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATHFNDR-2 studies Additional PALSONIFY presentations demonstrate [...]
Fat Burner For Men Launched Over the Counter in USA – PhenQ Medically Accredited Thermogenic Fat Burning Supplement for Men
13/07/2025
PhenQ 2025 OTC Fat Burner for Men: Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust. Glasgow, UK, July 13, 2025 (GLOBE NEWSWIRE) -- Introduction: Why PhenQ [...]
MSP Recovery Law Firm Secures Major Legal Win for MSP Recovery as Maryland Supreme Court Upholds Validity of Medicare Recovery Assignments for MSP Recovery and Its Healthcare Clients, Paving the Way for Medicare Recovery Rights Being Pursued Against GEICO
12/07/2025
MIAMI, July 12, 2025 (GLOBE NEWSWIRE) -- MSP Recovery Law Firm, counsel to MSP Recovery and its affiliated healthcare clients, announces a major legal victory following a decision by the Supreme Court of Maryland in the [...]
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
13/07/2025
- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data from Phase 3 TRANSCEND study underscore potential efficacy of setmelanotide, including with [...]
Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq
11/07/2025
Profusa's Common Stock is Expected to Begin Trading on Nasdaq on Monday, July 14, 2025 Under the Ticker "PFSA" BERKELEY, Calif, July 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA [...]
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/07/2025
WOBURN, Mass., July 11, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of [...]

Pages